Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantSHOEI UNIVERSAL CORPORATION PTE LTD
Licence HolderSHOEI UNIVERSAL CORPORATION PTE LTD
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
INJECTION, POWDER, FOR SOLUTION
INTRAVENOUS
Medical Information
L01AX04
dacarbazine
Manufacturer Information
SHOEI UNIVERSAL CORPORATION PTE LTD
DAE HAN NEW PHARM. CO. LTD.